New Chinese treatment for Covid-19 approved by 15 countries

JS016, a treatment for Covid-19 has been approved for emergency use by 15 countries, with the combination of another neutralizing antibody, according to information relayed by the CCTV News channel on November 19.

Protected by the Chinese Independent Intellectual Property Rights Law, this treatment was co-developed by Junshi Biosciences and the Institute of Microbiology of the Chinese Academy of Sciences.…

Visit the original:

Comments are closed.